Monday 13 October 2014

Pfizer breast cancer drug to get FDA priority review

The US Food and Drug Administration has granted priority review for palbociclib, which would treat certain postmenopausal women with advanced breast cancer, Pfizer said Washington (AFP) - Pfizer said Monday an experimental breast cancer treatment will be given an accelerated review by US regulators, speeding up the process for potential approval.




via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment